Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Now apply it to the providers shoppers see first
Okeke IG et al
Semaglutide and obesity: STEP1 clinical trial Summary of STEP 1 trial: Patients treated with high dose once weekly semaglutide 2.4mg injections (WeGovy) lost a significant amount of weight over a 68 week period
A randomized clinical trial published in JAMA Psychiatry offers preliminary evidence: | JAMA Psychiatry
PubMed laboratory research record [PMID: 8330353] PubMed record related to this compound for laboratory literature review
Under pilot programs tied to negotiated pricing, Medicare now covers GLP-1s for chronic weight management for qualifying beneficiaries
US$ 22.62
US$ 27.23
US$ 20.57
US$ 23.73
US$ 25.75
US$ 21.26
US$ 25.72
US$ 23.55
